ATRA

Atara Biotherapeutics Stock Analysis

AI Rating

Good
  • Quality6/10
  • Growth↑ 8/10
  • Momentum↓ 0/10
Atara Biotherapeutics sales and earnings growth
ATRA Growth
Good
  • Revenue Y/Y↑ 51.27%
  • EPS Y/Y↑ 113.05%
  • FCF Y/Y↑ 26.82%
Atara Biotherapeutics gross and profit margin trends
ATRA Profitability
Great
  • Gross margin ↑ 81.60%
  • EPS margin↑ 15.40%
  • ROIC↑ 52.40%
Atara Biotherapeutics net debt vs free cash flow
ATRA Risk
Great
  • Debt / Equity↓ -1.5
  • Debt / FCF↓ 0.7
  • Interest coverage↑ 7.0

Atara Biotherapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗